We understand that these physiological changes can be daunting, which is why we emphasize a transparent and empathetic approach
However, only a qualified medical provider can determine whether GLP-1 treatment is appropriate
Further studies have demonstrated that the immunosuppressant mycophenolate mofetil significantly reduces IL-1 and IL-2 expression, reverses associated pathological changes, and improves behavioral outcomes in TLE-D animal models (Mazumder et al., 2019)
Wang X, Xu Z, Ren X, et al
Receive a Personalized Treatment Plan If treatment is recommended, your provider creates a plan tailored to your health needs and goals
Crucially, patients consistently described this experience as qualitatively different from dieting